9160 Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices 

for conduct relating to the importation 

of any drug or controlled substance into 

the United States because Mr. Gagne 

was involved in a scheme to illegally 

import and introduce misbranded 

prescription drugs into the United 

States. In proposing a debarment period, 

FDA weighed the considerations set 

forth in section 306(c)(3) of the FD&C 

Act that it considered applicable to Mr. 

Gagne’s offense and concluded that the 

offense warranted the imposition of a 5- 

year period of debarment. 

The proposal informed Mr. Gagne of 

the proposed debarment and offered 

him an opportunity to request a hearing, 

providing him 30 days from the date of 

receipt of the letter in which to file the 

request, and advised him that failure to 

request a hearing constituted a waiver of 

the opportunity for a hearing and of any 

contentions concerning this action. Mr. 

Gagne received the proposal and notice 

of opportunity for a hearing on 

December 6, 2023. Mr. Gagne failed to 

request a hearing within the timeframe 

prescribed by regulation and has, 

therefore, waived his opportunity for a 

hearing and waived any contentions 

concerning his debarment (21 CFR part 

12). 

II. Findings and Order 

Therefore, the Assistant 

Commissioner, Office of Human and 

Animal Food Operations, under section 

306(b)(3)(C) of the FD&C Act, under 

authority delegated to the Assistant 

Commissioner, finds that Mr. Brendon 

Gagne has been convicted of a felony 

under Federal law for conduct relating 

to the importation into the United States 

of any drug or controlled substance. 

FDA finds that the offense should be 

accorded a debarment period of 5 years 

as provided by section 306(c)(2)(A)(iii) 

of the FD&C Act. 

As a result of the foregoing finding, 

Mr. Gagne is debarred for a period of 5 

years from importing or offering for 

import any drug into the United States, 

effective (see DATES). Pursuant to section 

301(cc) of the FD&C Act (21 U.S.C. 

331(cc)), the importing or offering for 

import into the United States of any 

drug by, with the assistance of, or at the 

direction of Mr. Gagne is a prohibited 

act. 

Dated: February 6, 2024. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2024–02706 Filed 2–8–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission to OMB for 

Review and Approval; Public Comment 

Request; HRSA Grantee Satisfaction 

Survey 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, 

HRSA submitted an Information 

Collection Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval. Comments 

submitted during the first public review 

of this ICR will be provided to OMB. 

OMB will accept further comments from 

the public during the review and 

approval period. OMB may act on 

HRSA’s ICR only after the 30-day 

comment period for this notice has 

closed. 

DATES: Comments on this ICR should be 

received no later than March 11, 2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under Review—Open for 

Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request a copy of the clearance requests 

submitted to OMB for review, email 

Joella Roland, the HRSA Information 

Collection Clearance Officer, at 

paperwork@hrsa.gov or call (301) 443– 

3983. 

SUPPLEMENTARY INFORMATION: 

Information Collection Request Title: 

HRSA Grantee Satisfaction Survey: 

OMB No. 0906–0006—Revision. 

Abstract: HRSA plans to survey HRSA 

grant recipients to better understand 

their opinions about HRSA’s grants 

processes and to improve the way HRSA 

conducts business with them. This 

survey will focus on grantee customer 

satisfaction areas related to the grant life 

cycle, grantee relationships with HRSA 

staff (e.g., Project Officers, Grants 

Management Officers), technical 

assistance received from HRSA Bureaus 

and Offices, availability of grant 

resources, and grantee access to 

guidance and instructional documents, 

etc. The seven grants management areas, 

which are directly related to the grants 

life cycle, are: Customer Service/ 

Cooperation; Policies and Procedures; 

Pre-Award Phase; Award Phase; 

Reporting/Post-Award Administration; 

Technical Assistance; and Priorities for 

Improvement. Receiving this 

information from external customers 

will provide HRSA with a repository of 

information that will be incorporated 

into strategic efforts to improve grants 

management services and customer 

service. 

HRSA revised the planned survey to 

reflect a change in the sampling 

methodology. In past survey 

administration cycles, HRSA sent a 

single survey to each organization and 

asked them to complete the survey for 

the award they had received from HRSA 

for the longest time period. This past 

approach did not allow for a range of 

program-specific feedback from HRSA 

grantees. In this survey administration 

cycle, HRSA will send the survey to 

each individual grant project director 

and ask them to complete the survey for 

a specific award. This new approach 

will enable HRSA to obtain more 

granular and actionable information 

regarding the full range of grant awards 

received by HRSA awardees. 

Compared to the 60-day Federal 

Register notice, HRSA anticipates the 

number of potential survey respondents 

will increase from 3,690 to 7,813 due to 

the change in the sampling 

methodology. HRSA also anticipates an 

increase in the burden hours compared 

to the 60-day Federal Register notice, 

based on a reassessment of the time 

completion of the survey conducted 

during a pre-test. The adjusted average 

of completing the survey is 0.34 hours 

per response. 

A 60-day notice for this information 

collection was published in the Federal 

Register on March 10, 2023, Vol. 88, No. 

47; pp. 15053. There were no public 

comments. 

Need and Proposed Use of the 

Information: The HRSA Grantee 

Satisfaction Survey will provide 

meaningful and relevant results to 

agency decision-makers about various 

customer satisfaction domains (e.g., 

efficiency, timeliness, usefulness, 

responsiveness, quality of and overall 

satisfaction with HRSA project officers, 

products and services). The information 

collected will assist HRSA in its efforts 

to gauge, understand and respond to the 

needs and concerns of its customers, 

especially as they relate to the 

aforementioned areas. The survey 

results will provide HRSA with concrete 

indicators regarding the best areas in 

which to dedicate resources to improve 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 28 / Friday, February 9, 2024 / Notices 9161 

customer service. HRSA will use this 

information to support agency-wide 

continuous quality improvement efforts. 

HRSA will use survey results to 

improve the efficiency, quality, and 

timeliness of its grants business 

processes, as well as to strengthen its 

partnership with external customers. 

Likely Respondents: Individuals who 

are identified as the project director for 

a current HRSA grant award. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

HRSA Grantee Satisfaction Survey ..................................... 7,813 0.32 2,500 0.34 850 

Total .............................................................................. 7,813 ........................ 2,500 ........................ 850 

* HRSA will send the survey to 7,813 potential respondents. Based on HRSA Grantee Satisfaction Surveys administered in previous years,

HRSA estimates a 32 percent response rate. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–02730 Filed 2–8–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of the President’s 

Advisory Commission on Asian 

Americans, Native Hawaiians, and 

Pacific Islanders Meeting and 

Solicitation for Oral and Written 

Comments 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of Intergovernmental and 

External Affairs, White House Initiative 

on Asian Americans, Native Hawaiians, 

and Pacific Islanders. 

ACTION: Notice of meeting and 

solicitation for written and oral 

comments. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

announces the next meeting of the 

President’s Advisory Commission on 

Asian Americans, Native Hawaiians, 

and Pacific Islanders (Commission) and 

the solicitation of written and oral 

comment regarding the advancement of 

equity, justice, and opportunity for 

Asian American, Native Hawaiian, and 

Pacific Islander (AA and NHPI) 

communities. The meeting is open to 

the public and will be held in Clark 

County, Nevada. Virtual attendance will 

be available through livestream on 

February 27 and in-person attendance 

will be available on February 28, 2024. 

The Commission is working to 

accomplish its mission to provide 

independent advice and 

recommendations to the President on 

ways to advance equity, justice, and 

opportunity for AA and NHPI 

communities. 

DATES: The Commission will meet on 

February 27, 2024, from 11:45 a.m. 

Eastern Time (ET) to 8:30 p.m. ET and 

February 28, 2024, from 12:00 p.m. ET 

to 4:00 p.m. ET. The final location and 

agenda will be posted on the website for 

the President’s Advisory Commission 

on Asian Americans, Native Hawaiians, 

and Pacific Islanders: https://

www.hhs.gov/about/whiaanhpi/ 

commission/index.html when this 

information becomes available. 

ADDRESSES: Members of the public may 

attend the meeting virtually or in 

person, depending on the portion of the 

meeting. Registration is required 

through the following links: 

February 27 meeting (virtual 

attendance only): https://www.event

brite.com/e/public-meeting-of-thepresidents-commission-on-aa-andnhpis-tickets814521895917?aff=oddtdtcreator. 

February 28 public listening session 

(in-person attendance only): https://

www.eventbrite.com/e/white-houseinitiative-aa-and-nhpi-communityengagement-event-nevada-tickets814515466687?aff=oddtdtcreator. 

FOR FURTHER INFORMATION CONTACT: 

Judith Teruya, Designated Federal 

Officer, President’s Advisory 

Commission on Asian Americans, 

Native Hawaiians, and Pacific Islanders, 

U.S. Department of Health and Human 

Services, Office of the Secretary, Office 

of Intergovernmental and External 

Affairs, U.S. Department of Health and 

Human Services, Hubert Humphrey 

Building, 620E, 200 Independence Ave. 

SW, Washington, DC 20201; email: 

AANHPICommission@hhs.gov; 

telephone: (202) 951–0235. 

SUPPLEMENTARY INFORMATION: 

Background: The meeting is the 

eighth in a series of federal advisory 

committee meetings regarding the 

development of recommendations to 

advance equity, justice, and opportunity 

for AA and NHPI communities. The 

meeting is open to the public and will 

be live streamed. The Commission, cochaired by U.S. Health and Human 

Services Secretary Xavier Becerra and 

the U.S. Trade Representative 

Ambassador Katherine Tai, advises the 

President on: the development, 

monitoring, and coordination of 

executive branch efforts to advance 

equity, justice, and opportunity for AA 

and NHPI communities in the United 

States, including efforts to close gaps in 

health, socioeconomic, employment, 

and educational outcomes; policies to 

address and end anti-Asian bias, 

xenophobia, racism, and nativism, and 

opportunities for the executive branch 

to advance inclusion, belonging, and 

public awareness of the diversity and 

accomplishments of AA and NHPI 

people, cultures, and histories; policies, 

programs, and initiatives to prevent, 

report, respond to, and track anti-Asian 

hate crimes and hate incidents; ways in 

which the Federal Government can 

build on the capacity and contributions 

of AA and NHPI communities through 

equitable Federal funding, grantmaking, 

and employment opportunities; policies 

and practices to improve research and 

equitable data disaggregation regarding 

AA and NHPI communities; policies 


ddrumheller on DSK120RN23PROD with NOTICES1